Discovery of Decamidine as a New and Potent PRMT1 Inhibitor.

about

Computer-Aided Drug Design in Epigenetics.The Methylation Status of the Epigenome: Its Emerging Role in the Regulation of Tumor Angiogenesis and Tumor Growth, and Potential for Drug Targeting

P2860

Q55120002-FDB286A4-A10C-4E34-B2EA-B9FA684ED85F Q58789495-8D8ECD6B-D58E-4839-A0A4-2F2CC488DC25

P2860

Discovery of Decamidine as a New and Potent PRMT1 Inhibitor.

Item

http://www.wikidata.org/entity/Q49194043

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Discovery of Decamidine as a New and Potent PRMT1 Inhibitor.

@en

Discovery of Decamidine as a New and Potent PRMT1 Inhibitor.

@nl

type

Item

label

Discovery of Decamidine as a New and Potent PRMT1 Inhibitor.

@en

Discovery of Decamidine as a New and Potent PRMT1 Inhibitor.

@nl

prefLabel

Discovery of Decamidine as a New and Potent PRMT1 Inhibitor.

@en

Discovery of Decamidine as a New and Potent PRMT1 Inhibitor.

@nl

P1476

Discovery of Decamidine as a New and Potent PRMT1 Inhibitor.

@en

P2093

Brenson A Jassim

http://www.w3.org/2001/XMLSchema#string

Chunli Yan

http://www.w3.org/2001/XMLSchema#string

Jing Zhang

http://www.w3.org/2001/XMLSchema#string

Maomao He

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of the conserved core of protein arginine methyltransferase PRMT3

An allosteric inhibitor of protein arginine methyltransferase 3

VMD: visual molecular dynamics

Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia.

Pharmacophore-based virtual screening and biological evaluation of small molecule inhibitors for protein arginine methylation

Novel therapeutic agents for cutaneous T-Cell lymphoma.

A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases.

Small Molecule Inhibitors of Protein Arginine Methyltransferases.

Diamidine compounds for selective inhibition of protein arginine methyltransferase 1.

HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications.

P304

440-444

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C6MD00573J

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yujun George Zheng

Ivaylo Ivanov

Kun Qian

P577

2017-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28649316

http://www.w3.org/2001/XMLSchema#string

P932

5477784

http://www.w3.org/2001/XMLSchema#string

Discovery of Decamidine as a New and Potent PRMT1 Inhibitor.

about

P2860

P2860

Discovery of Decamidine as a New and Potent PRMT1 Inhibitor.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932